The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

N,N-Dimethyl-5-methoxytryptamine     2-(5-methoxy-1H-indol-3-yl)- N,N-dimethyl...

Synonyms: MeODMT, Lopac-M-2381, CHEMBL7257, AGN-PC-00SV3H, SureCN132733, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of N,N-Dimethyl-5-methoxytryptamine


Psychiatry related information on N,N-Dimethyl-5-methoxytryptamine


High impact information on N,N-Dimethyl-5-methoxytryptamine


Chemical compound and disease context of N,N-Dimethyl-5-methoxytryptamine


Biological context of N,N-Dimethyl-5-methoxytryptamine


Anatomical context of N,N-Dimethyl-5-methoxytryptamine


Associations of N,N-Dimethyl-5-methoxytryptamine with other chemical compounds


Gene context of N,N-Dimethyl-5-methoxytryptamine


Analytical, diagnostic and therapeutic context of N,N-Dimethyl-5-methoxytryptamine


  1. Hypotensive spinal serotonergic effect. Are S1 or S2 receptors involved? Berger, A., Ramirez, A.J. Hypertension (1988) [Pubmed]
  2. 5-Methoxy-N,N-dimethyltryptamine: spinal cord and brainstem mediation of excitatory effects on acoustic startle. Davis, M., Astrachan, D.I., Gendelman, P.M., Gendelman, D.S. Psychopharmacology (Berl.) (1980) [Pubmed]
  3. Rats and marmosets respond differently to serotonin agonists and antagonists. Campos, M.F., Rodrigues F das, C. Psychopharmacology (Berl.) (1987) [Pubmed]
  4. Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N,N-dimethyltryptamine) in a feline model of photosensitive epilepsy. Wada, Y., Hasegawa, H., Nakamura, M., Yamaguchi, N. Neurosci. Lett. (1992) [Pubmed]
  5. Selective cross-tolerance to 5-HT1A and 5-HT2 receptor-mediated temperature and corticosterone responses. Nash, J.F., Meltzer, H.Y., Gudelsky, G.A. Pharmacol. Biochem. Behav. (1989) [Pubmed]
  6. Learning deficits after unilateral AF64A lesions in the rat basal forebrain: role of cholinergic and noncholinergic systems. Nakamura, S., Tani, Y., Maezono, Y., Ishihara, T., Ohno, T. Pharmacol. Biochem. Behav. (1992) [Pubmed]
  7. Effects of 5-HT2 receptor antagonist on cycloheximide-induced amnesia in mice. Nabeshima, T., Itoh, K., Kawashima, K., Kameyama, T. Pharmacol. Biochem. Behav. (1989) [Pubmed]
  8. The effect of a hallucinogen, 5-methoxy N,N-dimethyltryptamine, on primate social behavior. Schlemmer, R.F., Narasimhachari, N., Thompson, V.D., Davis, J.M. Communications in psychopharmacology. (1977) [Pubmed]
  9. Three serotonin responses in cultured mouse hippocampal and striatal neurons. Yakel, J.L., Trussell, L.O., Jackson, M.B. J. Neurosci. (1988) [Pubmed]
  10. Effects of two 5-hydroxytryptamine agonists on head-weaving behaviour in streptozotocin-diabetic mice. Fujii, E., Nomoto, T., Muraki, T. Diabetologia (1991) [Pubmed]
  11. Neurophysiological effects of hallucinogens on serotonergic neuronal systems. McCall, R.B. Neuroscience and biobehavioral reviews. (1982) [Pubmed]
  12. Inhibition of synaptosomal neurotransmitter uptake by hallucinogens. Whipple, M.R., Reinecke, M.G., Gage, F.H. J. Neurochem. (1983) [Pubmed]
  13. Biogenesis of 5-methoxy-N,N-dimethyltryptamine in human pineal gland. Guchhait, R.B. J. Neurochem. (1976) [Pubmed]
  14. Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP. Sills, M.A., Lucki, I., Frazer, A. Life Sci. (1985) [Pubmed]
  15. Serotonin receptor sensitivity after acute and chronic treatment with mianserin. Blackshear, M.A., Sanders-Bush, E. J. Pharmacol. Exp. Ther. (1982) [Pubmed]
  16. Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Gudelsky, G.A., Koenig, J.I., Meltzer, H.Y. Neuropharmacology (1986) [Pubmed]
  17. Inhibition of phrenic and sympathetic vasomotor neurons in cats by the serotonin analog 5-methoxy-N,N-dimethyltryptamine. Lalley, P.M. J. Pharmacol. Exp. Ther. (1982) [Pubmed]
  18. Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. May, J.A., McLaughlin, M.A., Sharif, N.A., Hellberg, M.R., Dean, T.R. J. Pharmacol. Exp. Ther. (2003) [Pubmed]
  19. Evidence for 5-HT2 receptor involvement in the stimulation of preovulatory LH and prolactin release and ovulation in normal cycling rats. Tanaka, E., Baba, N., Toshida, K., Suzuki, K. Life Sci. (1993) [Pubmed]
  20. Involvement of a central dopaminergic system in 5-methoxy-N,N-dimethyltryptamine-induced turning behaviour in rats with lesions of the dorsal raphé nuclei. Blackburn, T.P., Cox, B., Lee, T.F. Psychopharmacology (Berl.) (1982) [Pubmed]
  21. Indolealkylamines and prolactin secretion. A structure-activity study in the central nervous system of the rat. Seeman, G., Brown, G.M. Neuropharmacology (1985) [Pubmed]
  22. The role of 5-HT(1A) receptors in control of lower urinary tract function in cats. Thor, K.B., Katofiasc, M.A., Danuser, H., Springer, J., Schaus, J.M. Brain Res. (2002) [Pubmed]
  23. Two kinds of modification by 5-methoxy-N,N-dimethyltryptamine of contractile responses to electrical stimulation of isolated guinea-pig vas deferens. Yoshida, S., Kuga, T. Jpn. J. Pharmacol. (1987) [Pubmed]
  24. [3H]serotonin binding sites in goldfish retinal membranes. Lima, L., Radtke, I., Drujan, B. Neurochem. Res. (1992) [Pubmed]
  25. Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. Kelland, M.D., Freeman, A.S., Chiodo, L.A. J. Pharmacol. Exp. Ther. (1990) [Pubmed]
  26. Properties of some 1-arylpiperazines as antagonists of stereotyped behaviors mediated by central serotonergic receptors in rodents. Simansky, K.J., Schechter, L.E. J. Pharmacol. Exp. Ther. (1988) [Pubmed]
  27. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan, M.J., Bervoets, K., Colpaert, F.C. J. Pharmacol. Exp. Ther. (1991) [Pubmed]
  28. 5-Methoxy-N,N-dimethyltryptamine-induced analgesia is blocked by alpha-adrenoceptor antagonists in rats. Archer, T., Danysz, W., Jonsson, G., Minor, B.G., Post, C. Br. J. Pharmacol. (1986) [Pubmed]
  29. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors. Backus, L.I., Sharp, T., Grahame-Smith, D.G. Br. J. Pharmacol. (1990) [Pubmed]
  30. Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors. Alhaider, A.A., Hamon, M., Wilcox, G.L. Eur. J. Pharmacol. (1993) [Pubmed]
  31. Suppressive effects of isorhynchophylline on 5-HT2A receptor function in the brain: behavioural and electrophysiological studies. Matsumoto, K., Morishige, R., Murakami, Y., Tohda, M., Takayama, H., Sakakibara, I., Watanabe, H. Eur. J. Pharmacol. (2005) [Pubmed]
  32. Canine basilar artery contractions mediated by 5-hydroxytryptamine1A receptors. Peroutka, S.J., Huang, S., Allen, G.S. J. Pharmacol. Exp. Ther. (1986) [Pubmed]
  33. Central action of ipsapirone, a new anxiolytic drug, on serotoninergic, noradrenergic and dopaminergic functions. Maj, J., Chojnacka-Wójcik, E., Tatarczyńska, E., Kłodzińska, A. J. Neural Transm. (1987) [Pubmed]
  34. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats. Deakin, J.F., Green, A.R. Br. J. Pharmacol. (1978) [Pubmed]
  35. Nociception is enhanced by the intrathecal injection of 5-methoxy-N,N-dimethyltryptamine in the rat. Larson, A.A. Neurosci. Lett. (1982) [Pubmed]
  36. Central serotonergic responses and behavioural adaptation to repeated immobilisation: the effect of the corticosterone synthesis inhibitor metyrapone. Kennett, G.A., Dickinson, S.L., Curzon, G. Eur. J. Pharmacol. (1985) [Pubmed]
  37. Gas chromatographic-mass spectroscopic characterisation of the psychotomimetic indolealkylamines and their in vivo metabolites. Sitaram, B.R., Lockett, L., McLeish, M., Hayasaka, Y., Blackman, G.L., McLeod, W.R. J. Chromatogr. (1987) [Pubmed]
WikiGenes - Universities